BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26038203)

  • 1. The genetics of adrenocortical tumors.
    Espiard S; Bertherat J
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of tumors of the adrenal cortex.
    Bonnet-Serrano F; Bertherat J
    Endocr Relat Cancer; 2018 Mar; 25(3):R131-R152. PubMed ID: 29233839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5th International ACC Symposium: The New Genetics of Benign Adrenocortical Neoplasia: Hyperplasias, Adenomas, and Their Implications for Progression into Cancer.
    Kirschner LS; Stratakis CA
    Horm Cancer; 2016 Feb; 7(1):9-16. PubMed ID: 26684645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
    Faillot S; Assie G
    Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
    Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
    Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical tumorigenesis: Lessons from genetics.
    Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Adrenocortical Development and Tumors.
    Lodish M
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):419-433. PubMed ID: 28476230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
    Pusantisampan T; Sangkhathat S; Kayasut K; Kanngurn S; Jaruratanasirikul S; Chotsampancharoen T; Kritsaneepaiboon S
    Pediatr Dev Pathol; 2010; 13(3):238-42. PubMed ID: 19863445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.
    Drougat L; Omeiri H; Lefèvre L; Ragazzon B
    Front Endocrinol (Lausanne); 2015; 6():96. PubMed ID: 26106367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
    Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.
    Tadjine M; Lampron A; Ouadi L; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):264-70. PubMed ID: 17854394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.